NWALX
Price
$37.45
Change
+$0.15 (+0.40%)
Updated
Oct 6 closing price
Net Assets
749.54M
RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

NWALX vs RMFCX

Header iconNWALX vs RMFCX Comparison
Open Charts NWALX vs RMFCXBanner chart's image
Nationwide BNY Mellon Dyn US Eq Inc A
Price$37.45
Change+$0.15 (+0.40%)
VolumeN/A
Net Assets749.54M
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
NWALX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
NWALX vs. RMFCX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWALX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. NWALX (750M). NWALX pays higher dividends than RMFCX: NWALX (1.35) vs RMFCX (1.20). NWALX was incepted earlier than RMFCX: NWALX (6 years) vs RMFCX (23 years). NWALX (1.20) is less costly to investors than RMFCX (0.91). NWALX is a more actively managed with annual turnover of: 77.00 vs. RMFCX (31.00). RMFCX has a lower initial minimum investment than NWALX: RMFCX (250) vs NWALX (2000). RMFCX annual gain was more profitable for investors over the last year : 7.44 vs. NWALX (-3.57). RMFCX return over 5 years is better than : 60.80 vs. NWALX (35.62).
NWALXRMFCXNWALX / RMFCX
Total Expense Ratio1.100.91121%
Annual Report Gross Expense Ratio1.200.91132%
Fund Existence6 years23 years-
Gain YTD13.79214.96492%
Front Load6%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets750M112B1%
Annual Yield % from dividends1.351.20112%
Returns for 1 year-3.577.44-48%
Returns for 3 years21.8543.8450%
Returns for 5 years35.6260.8059%
Returns for 10 yearsN/A94.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.